Antimüllerian hormone serum levels: a putative marker for ovarian aging
- PMID: 11821097
- DOI: 10.1016/s0015-0282(01)02993-4
Antimüllerian hormone serum levels: a putative marker for ovarian aging
Abstract
Objective: To investigate whether serum concentrations of antimüllerian hormone may be used as a marker for ovarian aging.
Design: Longitudinal observational study.
Setting: Academic research center.
Patients: Forty-one normo-ovulatory premenopausal women and 13 healthy postmenopausal women.
Main outcome measure(s): Concentrations of serum antimüllerian hormone (assessed on two occasions 2.6 +/- 1.7 years apart), FSH, inhibin B, and estradiol and number of ovarian follicles on ultrasonography.
Result(s): Concentrations of antimüllerian hormone decreased significantly over time (median value, 2.1 microg/L [range, 0.1-7.4 microg/L] at visit 1 vs. 1.3 microg/L [range, 0.0-5.0 microg/L] at visit 2), whereas the number of antral follicles and levels of FSH and inhibin B did not change. During visits 1 and 2, concentrations of antimüllerian hormone correlated with age (r = -.40, P=.01 and r = -.57, P<.001, respectively); number of antral follicles (r =.66, P<.001 and r =.71, P<.001); and, to a lesser extent, with FSH level (r = -.29, P=.07 and r = -.37, P<.05) but not with inhibin B levels.
Conclusion(s): Serum concentrations of antimüllerian hormone decreased over time in young normo-ovulatory women, whereas other markers associated with ovarian aging did not change. Concentrations of antimüllerian hormone correlate with the number of antral follicles and age and less strongly with FSH level. Concentrations of antimüllerian hormone may be a novel marker for ovarian aging.
Republished in
-
Reprint of: Antimüllerian hormone serum levels: a putative marker for ovarian aging.Fertil Steril. 2019 Oct;112(4 Suppl1):e183-e188. doi: 10.1016/j.fertnstert.2019.08.088. Fertil Steril. 2019. PMID: 31623731 No abstract available.
Similar articles
-
Antimüllerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol.Am J Obstet Gynecol. 1996 Mar;174(3):958-65. doi: 10.1016/s0002-9378(96)70333-2. Am J Obstet Gynecol. 1996. PMID: 8633676 Clinical Trial.
-
Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.Hum Reprod. 2003 Feb;18(2):323-7. doi: 10.1093/humrep/deg042. Hum Reprod. 2003. PMID: 12571168
-
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.Hum Reprod. 2002 Dec;17(12):3065-71. doi: 10.1093/humrep/17.12.3065. Hum Reprod. 2002. PMID: 12456604
-
[Oocyte quality and ovarian reserve].J Gynecol Obstet Biol Reprod (Paris). 2006 Sep;35(5 Pt 2):2S35-2S36. J Gynecol Obstet Biol Reprod (Paris). 2006. PMID: 17057620 Review. French.
-
Anti-Müllerian hormone: a new marker for ovarian function.Reproduction. 2006 Jan;131(1):1-9. doi: 10.1530/rep.1.00529. Reproduction. 2006. PMID: 16388003 Review.
Cited by
-
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women.Fertil Steril. 2012 Nov;98(5):1254-9.e1-2. doi: 10.1016/j.fertnstert.2012.07.1139. Epub 2012 Aug 24. Fertil Steril. 2012. PMID: 22921911 Free PMC article.
-
Gene variants associated with age at menopause are also associated with polycystic ovary syndrome, gonadotrophins and ovarian volume.Hum Reprod. 2015 Jul;30(7):1697-703. doi: 10.1093/humrep/dev110. Epub 2015 May 20. Hum Reprod. 2015. PMID: 25994816 Free PMC article. Clinical Trial.
-
Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk.J Adolesc Young Adult Oncol. 2016 Dec;5(4):337-343. doi: 10.1089/jayao.2016.0009. Epub 2016 Aug 11. J Adolesc Young Adult Oncol. 2016. PMID: 27513691 Free PMC article.
-
Correlation of serum anti-Mullerian hormone with hormonal and environmental parameters in Brazilian climacteric women.Sci Rep. 2022 Jul 14;12(1):12065. doi: 10.1038/s41598-022-15429-7. Sci Rep. 2022. PMID: 35835777 Free PMC article.
-
Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.J Clin Endocrinol Metab. 2013 Dec;98(12):4629-38. doi: 10.1210/jc.2013-2375. Epub 2013 Sep 24. J Clin Endocrinol Metab. 2013. PMID: 24064685 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources